China NMPA Product Recall - Flash Glucose Monitoring System

The National Medical Products Administration (NMPA) announced on April 25, 2023, a voluntary Class I recall initiated by Abbott Diabetes Care Ltd. concerning its Flash Glucose Monitoring System. This recall, reported by Abbott Trading (Shanghai) Co., Ltd., was prompted by significant safety concerns identified in the product's scanning detector. Specifically, the lithium-ion battery within these devices presents a potential risk of swelling, overheating, and, in rare instances, fire. The manufacturer, Abbott Diabetes Care Inc., undertook this corrective action due to the seriousness of these battery-related malfunctions. A Class I recall is issued when there is a reasonable probability that using or being exposed to the product could lead to serious adverse health consequences or death, highlighting the critical nature of the identified defect. The recall documentation, referenced by NMPA Index No. JGXX-2023-10075 and associated with National Medical Device Registration Certificate No. 20163072472, advises interested parties to consult the 'Medical Device Recall Event Report Form' for detailed information on affected product models and further necessary actions. This regulatory intervention aims to ensure patient safety by removing potentially hazardous devices from circulation.